Related Experiment Video
Updated: Aug 3, 2026
10:28
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.9K
On Flanigan's Pharmaceutical Freedom
1School of Philosophy, University of Southern California, Los Angeles, CA, USA. quong@usc.edu.
Summary
This paper examines Jessica Flanigan's "Pharmaceutical Freedom," arguing for a coherent stance on informed consent without a self-medication right. It also explores the moral permissibility of taking medications without full payment, potentially justifying forceful acquisition.
Area of Science:
- Bioethics
- Philosophy of Medicine
- Pharmaceutical Ethics
Background:
- Critically analyzes Jessica Flanigan's "Pharmaceutical Freedom."
- Examines the ethical considerations of pharmaceutical access and patient autonomy.
- Addresses the tension between informed consent and the right to self-medicate.
Purpose of the Study:
- To present a coherent framework for informed consent that does not necessitate a right to self-medicate.
- To explore the ethical implications of Flanigan's arguments regarding medication acquisition.
- To investigate the moral permissibility of taking medications without full payment under certain conditions.
Main Methods:
- Philosophical argumentation and conceptual analysis.
- Critical engagement with Flanigan's ethical framework.
- Ethical reasoning on property rights, medication access, and justified force.
Main Results:
- A coherent reconciliation of the Doctrine of Informed Consent with the rejection of a right to self-medicate is proposed.
- Flanigan's work implies a more radical conclusion: moral permissibility of taking medications without full payment in some scenarios.
- The concept of permissible theft of medication is explored, with implications for the use of force.
Conclusions:
- The Doctrine of Informed Consent can be upheld without endorsing a right to self-medicate.
- Pharmaceutical acquisition ethics may permit taking medications without full payment under specific circumstances.
- Further ethical inquiry into justified force for medication access is warranted based on permissible theft principles.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:06Drug Clearance: Overview
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including the...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including the...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...